Polypharmacy as a risk factor for depressive symptoms in geriatric patients: an observational, cross-sectional study

Aim: The aim of this study was to investigate the correlation between polypharmacy and depressive symptoms in hospitalized adults aged over 65 years. Patients and methods: We obtained medical history and current treatment data from clinical records. We used the Abbreviated Mental Test Score (AMTS) t...

Full description

Bibliographic Details
Main Authors: Spandel Leszek, Jośko-Ochojska Jadwiga, Batko-Szwaczka Agnieszka
Format: Article
Language:English
Published: Facultad de Farmacia, Universidad de Granada
Series:Ars Pharmaceutica
Subjects:
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2340-98942016000300004&lng=en&tlng=en
id doaj-c8326ff7c3484cca8c2580d45f721cb6
record_format Article
spelling doaj-c8326ff7c3484cca8c2580d45f721cb62020-11-24T23:48:05ZengFacultad de Farmacia, Universidad de GranadaArs Pharmaceutica2340-989457313714210.4321/S2340-98942016000300004S2340-98942016000300004Polypharmacy as a risk factor for depressive symptoms in geriatric patients: an observational, cross-sectional studySpandel Leszek0Jośko-Ochojska Jadwiga1Batko-Szwaczka Agnieszka2Medical University of SilesiaMedical University of SilesiaMedical University of SilesiaAim: The aim of this study was to investigate the correlation between polypharmacy and depressive symptoms in hospitalized adults aged over 65 years. Patients and methods: We obtained medical history and current treatment data from clinical records. We used the Abbreviated Mental Test Score (AMTS) to exclude patients with dementia. The Geriatric Depression Scale (GDS) was used assess depressive symptoms. Pearson and Spearman coefficients were used to determine the relationship between variables. Results: A total of 206 individuals were included. The average number of medications taken by the individuals was 6.9 ± 2.7 and the average GDS score was 4.9 ± 3.4 points. Depressive symptoms (GDS score >5 points) were observed in 68 (33.0%) individuals. GDS score positively correlated with the number of medications used (R = 0.74; P = 0.0001), the number of chronic conditions (R = 0.78; P = 0.001), and pain complaints (Z = 7.94; P = 0.0001). A significant association between GDS score and the use of the following medications was observed: statins, cytostatic agents, corticosteroids, benzodiazepines, cardiac glycosides, non-steroidal anti-inflammatory drugs, muscle relaxants, non-psychotropic drugs with anticholinergic properties, and centrally acting analgesics (all P < 0.05). Conclusions: Our study indicates that polypharmacy is positively correlated with the presence of depressive symptoms in geriatric patients. We identified a number of medications associated with a higher prevalence of depressive symptoms, however these relationships require further examination.http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2340-98942016000300004&lng=en&tlng=enelderlyadverse drug effectsmental healthpsychiatry
collection DOAJ
language English
format Article
sources DOAJ
author Spandel Leszek
Jośko-Ochojska Jadwiga
Batko-Szwaczka Agnieszka
spellingShingle Spandel Leszek
Jośko-Ochojska Jadwiga
Batko-Szwaczka Agnieszka
Polypharmacy as a risk factor for depressive symptoms in geriatric patients: an observational, cross-sectional study
Ars Pharmaceutica
elderly
adverse drug effects
mental health
psychiatry
author_facet Spandel Leszek
Jośko-Ochojska Jadwiga
Batko-Szwaczka Agnieszka
author_sort Spandel Leszek
title Polypharmacy as a risk factor for depressive symptoms in geriatric patients: an observational, cross-sectional study
title_short Polypharmacy as a risk factor for depressive symptoms in geriatric patients: an observational, cross-sectional study
title_full Polypharmacy as a risk factor for depressive symptoms in geriatric patients: an observational, cross-sectional study
title_fullStr Polypharmacy as a risk factor for depressive symptoms in geriatric patients: an observational, cross-sectional study
title_full_unstemmed Polypharmacy as a risk factor for depressive symptoms in geriatric patients: an observational, cross-sectional study
title_sort polypharmacy as a risk factor for depressive symptoms in geriatric patients: an observational, cross-sectional study
publisher Facultad de Farmacia, Universidad de Granada
series Ars Pharmaceutica
issn 2340-9894
description Aim: The aim of this study was to investigate the correlation between polypharmacy and depressive symptoms in hospitalized adults aged over 65 years. Patients and methods: We obtained medical history and current treatment data from clinical records. We used the Abbreviated Mental Test Score (AMTS) to exclude patients with dementia. The Geriatric Depression Scale (GDS) was used assess depressive symptoms. Pearson and Spearman coefficients were used to determine the relationship between variables. Results: A total of 206 individuals were included. The average number of medications taken by the individuals was 6.9 ± 2.7 and the average GDS score was 4.9 ± 3.4 points. Depressive symptoms (GDS score >5 points) were observed in 68 (33.0%) individuals. GDS score positively correlated with the number of medications used (R = 0.74; P = 0.0001), the number of chronic conditions (R = 0.78; P = 0.001), and pain complaints (Z = 7.94; P = 0.0001). A significant association between GDS score and the use of the following medications was observed: statins, cytostatic agents, corticosteroids, benzodiazepines, cardiac glycosides, non-steroidal anti-inflammatory drugs, muscle relaxants, non-psychotropic drugs with anticholinergic properties, and centrally acting analgesics (all P < 0.05). Conclusions: Our study indicates that polypharmacy is positively correlated with the presence of depressive symptoms in geriatric patients. We identified a number of medications associated with a higher prevalence of depressive symptoms, however these relationships require further examination.
topic elderly
adverse drug effects
mental health
psychiatry
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2340-98942016000300004&lng=en&tlng=en
work_keys_str_mv AT spandelleszek polypharmacyasariskfactorfordepressivesymptomsingeriatricpatientsanobservationalcrosssectionalstudy
AT joskoochojskajadwiga polypharmacyasariskfactorfordepressivesymptomsingeriatricpatientsanobservationalcrosssectionalstudy
AT batkoszwaczkaagnieszka polypharmacyasariskfactorfordepressivesymptomsingeriatricpatientsanobservationalcrosssectionalstudy
_version_ 1725487335326351360